BioBusiness 2011
19 January 2011 - 20 January 2011
BioBusiness 2011 will provide with you two days of networking, case studies, roundtable discussions and investment challenges, ensuring you make the most of your experience at the forum.
Radisson Blu Portman Hotel, London, UK
http://www.biobusiness-conference.com
3rd Annual Risk Evaluation and Mitigation Strategies Summit
24 January 2011 - 25 January 2011
ExL’s 3rd Risk Evaluation and Mitigation Strategies (REMS) Summit brings some of the most experienced professionals in the industry together to determine when risks become regulatory mandates for mitigation and how the industry is responding. We examine the impact of mandates on your drug safety programs above and beyond normal operation, and how to best implement and ensure the effectiveness of your REMS programs.
Westin Arlington Gateway, Arlington, VA, USA
http://www.exlpharma.com/event-home/1557
6th Annual International Conference on Predictive Human Toxicity and ADME/Tox Studies
27 January 2011 - 28 January 2011
The desire to bring new drugs to market faster is a key driver of pharmaceutical companies. Being able to identify drug candidates faster with fewer missed hits has streamlined the screening process, but having insufficient knowledge of potential human toxicity early on can turn a successful drug into a devastating loss.
Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process.
Brussels, Belgium
http://www.mondialresearchgroup.com/index.php?whereTo=humt11
GTCbio's 9th Cytokines and Inflammation
27 January 2011 - 28 January 2011
In 2011, the conference will cover ever-important topics such as the TNF family, the inflammasome, chemokines, costimulation and innate immunity. In addition, timely coverage will be devoted to areas of current rapid expansion, such as the IL-17 and Th17 fields and JAK/STAT kinases, at a time when phase 2 and even phase 3 studies are being conducted and reported in these areas. Intriguing recently discovered cytokines, such as IL-25, novel alarmins and novel IL-1 family members will also be covered.
San Diego, CA, USA
http://gtcbio.com/conferenceDetails.aspx?id=171
GTCbio's 8th Cancer Drugs Research and Development
27 January 2011 - 28 January 2011
The 8th Annual Cancer Drugs Research and Development Conference on January 27-28, 2011 in San Diego, California, USA will provide an extensive look at the successes as well as the challenges that face modern cancer drug development and provide you with an update on cancer drugs currently in development through clinical trials. A look at live cancer vaccines, novel compounds and antibody drug conjugates will prime you with the future direction of cancer drugs with key topics to be discussed by leading experts.
Paradise Point Resort & Spa, San Diego, CA, USA
http://gtcbio.com/conferenceDetails.aspx?id=169
GTCbio's 3rd Oncology Biomarkers
27 January 2011 - 28 January 2011
GTCbio’s 3rd Oncology Biomarkers Conference focuses on topics paramount to the continuing progress of biomarker research and development. This two-day summit will bring together top leaders from the pharmaceutical and biotechnology communities, officials from the FDA and NIH, and researchers from esteemed academic institutions to discuss the landscape of research, the challenges of regulations, and the future of biomarker opportunities
Paradise Point Resort & Spa, San Diego, CA, USA
http://gtcbio.com/conferenceDetails.aspx?id=142
Ubiquitin Research and Drug Discovery in Cancer
27 January 2011 - 28 January 2011
This meeting, taking place on January 27-28, 2011 in San Diego, CA, will bring together leaders from biotech and pharmaceutical companies, academia, and government, to provide you with a solid primer for a better understanding of the complex activities of ubiquitin and ubiquitin-like proteins and some solutions to the challenges associated with ubiquitin drug development.
Paradise Point Resort & Spa, San Diego, CA, USA
http://gtcbio.com/conferenceDetails.aspx?id=176
Advances In Integrative Medicine 2011
28 January 2011 - 30 January 2010
Waldorf Astoria/Disney Property, Orlando FL USA
http://www.theifim.com
Advances in Cell Based Screening Technologies
15 March 2011
ELRIG Announce Free Online Registration for Cell Based Screening, March 2011
ELRIG, the European Laboratory and Robotics Interest Group, announces free registration to ‘Advances in Cell Based Screening Technologies’ is now open online. This meeting is being held at Hinxton Hall on 15th March 2011.
At this conference we will hear talks on the latest cutting edge detection technologies and biological techniques transitioning into screening labs. How they are faring and what might we be using in 10 years’ time.
Hinxton Hall Cambridge, UK
http://www.elrig.org
Thermo Fisher Scientific - UK Summer Symposium Seminar
07 June 2011
The Symposium will include presentations from scientists both from within the company and key users from representative organisations who are utilising Thermo Scientific products and equipment to further their daily research. In addition, Thermo Scientific representatives will be available throughout the day to discuss any technical questions. A parallel exhibition will showcase the latest updates in Thermo Scientific products from across the company including scientific instrumentation, laboratory products, microbiology and cellomics as well as related products from selected third party suppliers to enhance your research and analyses.
QEII Conference Centre, London, UK
http://www.thermoscientific.com/uksummersymposium
High Throughput BioProcess Development
22 June 2011
This conference will bring together leading experts in a number of these fields in order to both look at the state of the art today and what may be available in the future. The meeting will consist of presentations covering early R&D in the area of Bioprocessing and also the move to use the information found by high through put methods to assist in the scale up process including the use of single-use components.
Daresbury Park Hotel, Warrington, UK
http://www.elrig.org/index.php/events/118-high-throughput-bioprocess-development/695-high-throughput-bioprocess-development
Poorly soluble drugs workshop
15 September 2011
The APGI (Association de Pharmacie Galénique Industrielle) is organizing for the first time a workshop dedicated to the appropriate formulation of poorly water-soluble drugs. During the one day event, oral and poster presentations from academia and industry as well as practical demonstrations (in small groups) are foreseen.
The University of Lille, College of Pharmacy, 3 Rue du Professeur Laguesse, 59006 Lille, France
http://www.apgi.org/2011_WS/
Blue pill pink pill? Does gender matter?
10 November 2011
The conference will examine the extent to which gender should be a factor in the development, regulation and use of medicines and discuss gender considerations in clinical practice. This is a joint event between the Royal Pharmaceutical Society (RPS), the Medical Women’s Federation (MWF), the National Association of Women Pharmacists (NAWP).
Royal Pharmaceutical Society, 1 Lambeth High Street, London SE1 7JN
http://www.rpharms.com/conferences/blue-pill-pink-pill-does-gender-matter.asp
Potential Utility of Epigenetic Therapies in Non-Cancerous Settings
06 December 2011
With epigenetic techniques becoming increasingly popular as a key part of efficient and effective therapies, this masterclass comes at the perfect time to provide attendees with an advanced review of current therapies as well as the future development of biomarkers and diagnostics.
Holiday Inn Bloomsbury, London, UK
http://www.smi-online.co.uk/training/overview.asp?is=4&ref=3882